Pathogen inactivation of human serum facilitates its clinical use for islet cell culture and subsequent transplantation

Cell Transplantation

Volumn 20, Issue 5, 2011, Pages 775-781

  Ståhle, Magnus U ^a   Brandhorst, Daniel ^a   Korsgren, Olle ^a   Knutson, Folke ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell culture; Cell therapy; Cell transplantation; Pathogen inactivation; Serum

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOKINE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPLANTATION; CELL VIABILITY; DIABETES MELLITUS; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; QUALITY CONTROL; SERUM; TISSUE CULTURE; VIRUS INACTIVATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; DISINFECTION; HUMANS; INSULIN; INTERLEUKIN-6; INTERLEUKIN-8; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, NUDE; SERUM; THROMBOPLASTIN;

MUS; MUS MUSCULUS;

EID: 79959982259     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X539056     Document Type: Article

References (56)

1. Andersson, A. Isolated mouse pancreatic islets in culture: Effects of serum and different culture media on the insulin production of the islets. Diabetologia 14(6):397-404; 1978.
2. Andersson, A.; Borglund, E.; Brolin, S. Effects of glucose on the content of ATP and glycogen and the rate of glucose phosphorylation of isolated pancreatic islets maintained in tissue culture. Biochem. Biophys. Res. Commun. 56(4):1045-1051; 1974.
3. Bottino, R.; Inverardi, L.; Valente, U.; Ricordi, C. Serum- free medium and pyruvate improve survival and glucose responsiveness of islet beta cells in culture. Transplant. Proc. 29(4):1978; 1997.
4. Brandhorst, D.; Brandhorst, H.; Hering, B. J.; Bretzel, R. G. Long-term survival, morphology and in vitro func- tion of isolated pig islets under different culture conditions. Transplantation 67(12):1533-1541; 1999.
5. Brandhorst, D.; Brandhorst, H.; Hering, B. J.; Federlin, K.; Bretzel, R. G. The intracellular ATP content of fresh and cultured human islets isolated from different donors. Transplant. Proc. 29(4):1979; 1997.
6. Bretzel, R. G.; Brandhorst, D.; Brandhorst, H.; Eckhard, M.; Ernst, W.; Friemann, S.; Rau, W.; Weimar, B.; Rauber, K.; Hering, B. J.; Brendel, M. D. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritrans- plant management. J. Mol. Med. 77(1):140-143; 1999.
7. Buitrago, A.; Gylfe, E. Significance of serum for the preservation of insulin secretion during culture. Med. Biol. 61(2):133-138; 1983.
8. Castro, E.; Girones, N.; Bueno, J. L.; Carrion, J.; Lin, L.; Fresno, M. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inac- tivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 47(3):434-441; 2007.
9. Ciaravino, V.; Hanover, J.; Lin, L.; Sullivan, T.; Corash, L. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photo- chemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats. Transfusion 49(5):985-994; 2009.
10. Ciaravino, V.; McCullough, T.; Cimino, G.; Sullivan, T. Preclinical safety profile of plasma prepared using the IN- TERCEPT Blood System. Vox Sang. 85(3):171-182; 2003.
11. Ciaravino, V.; McCullough, T.; Dayan, A. D. Pharmaco-kinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum. Exp. Toxicol. 20(10): 533-550; 2001.
12. Drosten, C.; Gunther, S.; Preiser, W.; van der Werf, S.; Brodt, H. R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R. A.; Berger, A.; Burguiere, A. M.; Cinatl, J.; Eickmann, M.; Escriou, N.; Grywna, K.; Kramme, S.; Manuguerra, J. C.; Muller, S.; Rickerts, V.; Sturmer, M.; Vieth, S.; Klenk, H. D.; Osterhaus, A. D.; Schmitz, H.; Doerr, H. W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348(20):1967-1976; 2003.
13. Eagle, H. Nutrition needs of mammalian cells in tissue culture. Science 122(3168):501-514; 1955.
14. Fraga, D. W.; Sabek, O.; Hathaway, D. K.; Gaber, A. O. A comparison of media supplement methods for the ex- tended culture of human islet tissue. Transplantation 65(8):1060-1066; 1998.
15. Friberg, A.; Brandhorst, H.; Ståhle, M.; Svensson, A.; Korsgren, O.; Brandhorst, D. Digital image analysis of is- let samples yields consistent, reproducible results. Xeno- transplantation 14(5):389; 2007.
16. Friberg, A. S.; Ståhle, M.; Brandhorst, H.; Korsgren, O.; Brandhorst, D. Human islet separation utilizing a closed automated purification system. Cell Transplant. 17:1305-1313; 2008.
17. Gaber, A. O.; Fraga, D. W.; Callicutt, C. S.; Gerling, I. C.; Sabek, O. M.; Kotb, M. Y. Improved in vivo pancre- atic islet function after prolonged in vitro islet culture. Transplantation 72(11):1730-1736; 2001.
18. Goldman, H.; Colle, E. Human pancreatic islets in culture: Effects of supplementing the medium with homologous and heterologous serum. Science 192(4243):1014-1016; 1976.
19. Gospodarowicz, D.; Moran, J. S. Growth factors in mammalian cell culture. Annu. Rev. Biochem. 45:531-558; 1976.
20. Goto, M.; Eich, T. M.; Felldin, M.; Foss, A.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Fujimori, K.; Engkvist, M.; Korsgren, O. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 78(9):1367-1375; 2004.
21. Grellier, P.; Benach, J.; Labaied, M.; Charneau, S.; Gil, H.; Monsalve, G.; Alfonso, R.; Sawyer, L.; Lin, L.; Steiert, M.; Dupuis, K. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 48(8):1676-1684; 2008.
22. Hambleton, J.; Wages, D.; Radu-Radulescu, L.; Adams, M.; MacKenzie, M.; Shafer, S.; Lee, M.; Smyers, J.; Wiesehahn, G.; Corash, L. Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagu- lated with warfarin. Transfusion 42(10):1302-1307; 2002.
23. Hellman, B.; Idahl, L. A.; Sehlin, J.; Taljedal, I. B. Influence of anoxia on glucose metabolism in pancreatic islets: Lack of correlation between fructose-1,6-diphosphate and apparent glycolytic flux. Diabetologia 11(6):495-500; 1975.
24. Hering, B. J.; Kandaswamy, R.; Harmon, J. V.; Ansite, J. D.; Clemmings, S. M.; Sakai, T.; Paraskevas, S.; Eckman, P. M.; Sageshima, J.; Nakano, M.; Sawada, T.; Matsumoto, I.; Zhang, H. J.; Sutherland, D. E.; Bluestone, J. A. Transplantation of cultured islets from two-layer pre- served pancreases in type 1 diabetes with anti-CD3 anti- body. Am. J. Transplant. 4(3):390-401; 2004.
25. Holmes, M. A.; Clayton, H. A.; Chadwick, D. R.; Bell, P. R.; London, N. J.; James, R. F. Functional studies of rat, porcine, and human pancreatic islets cultured in ten commercially available media. Transplantation 60(8): 854-860; 1995.
26. Ihm, S. H.; Matsumoto, I.; Zhang, H. J.; Ansite, J. D.; Hering, B. J. Effect of short-term culture on functional and stress-related parameters in isolated human islets. Transpl. Int. 22(2):207-216; 2009.
27. Jahr, H.; Hussmann, B.; Eckhardt, T.; Bretzel, R. G. Successful single donor islet allotransplantation in the strepto- zotocin diabetes rat model. Cell Transplant. 11(6):513-518; 2002.
28. Jauvin, V.; Alfonso, R. D.; Guillemain, B.; Dupuis, K.; Fleury, H. J. In vitro photochemical inactivation of cell- associated human T-cell leukemia virus type I and II in human platelet concentrates and plasma by use of amotosalen. Transfusion 45(7):1151-1159; 2005.
29. Johansson, U.; Olsson, A.; Gabrielsson, S.; Nilsson, B.; Korsgren, O. Inflammatory mediators expressed in human islets of Langerhans: Implications for islet transplantation. Biochem. Biophys. Res. Commun. 308(3):474-479; 2003.
30. Kerr-Conte, J.; Vandewalle, B.; Moerman, E.; Lukowiak, B.; Gmyr, V.; Arnalsteen, L.; Caiazzo, R.; Sterkers, A.; Hubert, T.; Vantyghem, M. C.; Pattou, F. Upgrading pre- transplant human islet culture technology requires human serum combined with media renewal. Transplantation 89(9):1154-1160; 2010.
31. Klein, H. G. How safe is blood, really? Biologicals 38(1): 100-104; 2010.
32. Kuttler, B.; Hartmann, A.; Wanka, H. Long-term culture of islets abrogates cytokine-induced or lymphocyte- induced increase of antigen expression on beta cells. Transplantation 74(4):440-445; 2002.
33. Lee, R. H.; Carter, J.; Szot, G. L.; Posselt, A.; Stock, P. Human albumin preserves islet mass and function better than whole serum during pretransplantation islet culture. Transplant. Proc. 40(2):384-386; 2008.
34. Lin, L. Inactivation of cytomegalovirus in platelet concentrates using Helinx technology. Semin. Hematol. 38(4 Suppl. 11):27-33; 2001.
35. Lin, L.; Cook, D. N.; Wiesehahn, G. P.; Alfonso, R.; Behrman, B.; Cimino, G. D.; Corten, L.; Damonte, P. B.; Dikeman, R.; Dupuis, K.; Fang, Y. M.; Hanson, C. V.; Hearst, J. E.; Lin, C. Y.; Londe, H. F.; Metchette, K.; Nerio, A. T.; Pu, J. T.; Reames, A. A.; Rheinschmidt, M.; Tessman, J.; Isaacs, S. T.; Wollowitz, S.; Corash, L. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 37(4):423-435; 1997.
36. Lin, L.; Dikeman, R.; Molini, B.; Lukehart, S. A.; Lane, R.; Dupuis, K.; Metzel, P.; Corash, L. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 44(10):1496-1504; 2004.
37. Lin, L.; Hanson, C. V.; Alter, H. J.; Jauvin, V.; Bernard, K. A.; Murthy, K. K.; Metzel, P.; Corash, L. Inactivation of viruses in platelet concentrates by photochemical treat- ment with amotosalen and long-wavelength ultraviolet light. Transfusion 45(4):580-590; 2005.
38. Ling, Z.; Hannaert, J. C.; Pipeleers, D. Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 37(1):15-21; 1994.
39. Moberg, L.; Olsson, A.; Berne, C.; Felldin, M.; Foss, A.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Nilsson, B.; Korsgren, O. Nicotinamide inhibits tissue factor ex- pression in isolated human pancreatic islets: Implications for clinical islet transplantation. Transplantation 76(9): 1285-1288; 2003.
40. Nielsen, J. H. Growth and function of the pancreatic beta cell in vitro: Effects of glucose, hormones and serum fac- tors on mouse, rat and human pancreatic islets in organ culture. Acta Endocrinol. Suppl. 266:1-39; 1985.
41. Osselaer, J. C.; Cazenave, J. P.; Lambermont, M.; Garraud, O.; Hidajat, M.; Barbolla, L.; Tardivel, R.; Defoin, L.; Waller, C.; Mendel, I.; Raidot, J. P.; Kandel, G.; De Meuter, R.; Fabrigli, P.; Dehenau, D.; Arroyo, J. L.; Padron, F.; Gouezec, H.; Corral, M.; Jacquet, M.; Sundin, D.; Lin, L.; Corash, L. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox Sang. 94(4):315-323; 2008.
42. Osselaer, J. C.; Messe, N.; Hervig, T.; Bueno, J.; Castro, E.; Espinosa, A.; Accorsi, P.; Junge, K.; Jacquet, M.; Flament, J.; Corash, L. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 48(6):1061-1071; 2008.
43. Pappas, K. K.; Scott, 3rd, W. E.; Avgoustiniatos, E. S.; Nelson, R. A.; Rozak, P. R.; Ansite, J. D.; Fraga, D. W.; Wildey, G. M.; Boyd, V.; Hering, B. J. Effect of serum on fractional viability of human islets cultured for 2 days (abstract). 8th International Congress of the Cell Trans- plant Society, Milan, Italy; 2006.
44. Pealer, L. N.; Marfin, A. A.; Petersen, L. R.; Lanciotti, R. S.; Page, P. L.; Stramer, S. L.; Stobierski, M. G.; Signs, K.; Newman, B.; Kapoor, H.; Goodman, J. L.; Chamberland, M. E. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349(13):1236-1245; 2003.
45. Pineda, A.; McCullough, J.; Benjamin, R. J.; Cable, R.; Strauss, R. G.; Burgstaler, E.; Porter, S.; Lin, L.; Metzel, P.; Conlan, M. G. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: Process used in the SPRINT trial. Transfusion 46(4):562-571; 2006.
46. Rasongles, P.; Angelini-Tibert, M. F.; Simon, P.; Currie, C.; Isola, H.; Kientz, D.; Slaedts, M.; Jacquet, M.; Sundin, D.; Lin, L.; Corash, L.; Cazenave, J. P. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Reunion. Transfusion 49(6):1083-1091; 2009.
47. Roback, J. D.; Conlan, M.; Drew, W. L.; Ljungman, P.; Nichols, W. G.; Preiksaitis, J. K. The role of photochemi- cal treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfus. Med. Rev. 20(1):45-56; 2006.
48. Rush, B. T.; Fraga, D. W.; Kotb, M. Y.; Sabek, O. M.; Lo, A.; Gaber, L. W.; Halim, A. B.; Gaber, A. O. Preservation of human pancreatic islet in vivo function after 6- month culture in serum-free media. Transplantation 77(8): 1147-1154; 2004.
49. Rydgard, K. J.; Song, Z.; Foss, A.; Ostraat, O.; Tufveson, G.; Wennberg, L.; Lundgren, T.; Tibell, A.; Groth, C.; Korsgren, O. Procurement of human pancreases for islet isolation-the initiation of a Scandinavian collaborative network. Transplant. Proc. 33(4):2538; 2001.
50. Schlenke, P.; Hervig, T.; Isola, H.; Wiesel, M. L.; Kientz, D.; Pinkoski, L.; Singh, Y.; Lin, L.; Corash, L.; Cazenave, J. P. Photochemical treatment of plasma with amotosalen and UVA light: Process validation in three European blood centers. Transfusion 48(4):697-705; 2008
51. Singh, Y.; Sawyer, L. S.; Pinkoski, L. S.; Dupuis, K. W.; Hsu, J. C.; Lin, L.; Corash, L. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 46(7):1168-1177; 2006.
52. Snyder, E.; McCullough, J.; Slichter, S. J.; Strauss, R. G.; Lopez-Plaza, I.; Lin, J. S.; Corash, L.; Conlan, M. G. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: The SPRINT trial. Transfusion 45(12):1864-1875; 2005.
53. Solheim, B. G.; Seghatchian, J. The six questions of pathogen reduction technology: An overview of current opinions. Transfus. Apher. Sci. 39(1):51-57; 2008.
54. Ståhle, M.; Carlsson, B.; Le Blanc, K.; Korsgren, O.; Knutson, F. Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation. Vox Sang. 98:e364-e365; 2010.
55. Vamvakas, E. C.; Blajchman, M. A. Transfusion-related mortality: The ongoing risks of allogeneic blood transfu- sion and the available strategies for their prevention. Blood 113(15):3406-3417; 2009.
56. van Rhenen, D.; Gulliksson, H.; Cazenave, J. P.; Pamphilon, D.; Ljungman, P.; Kluter, H.; Vermeij, H.; Kappers- Klunne, M.; de Greef, G.; Laforet, M.; Lioure, B.; Davis, K.; Marblie, S.; Mayaudon, V.; Flament, J.; Conlan, M.; Lin, L.; Metzel, P.; Buchholz, D.; Corash, L. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial. Blood 101(6):2426-2433; 2003.